Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-26

Clinical Trial Update: FGF19 and Chronic Kidney Disease [NA]

View source ↗

Summary

A clinical trial investigating FGF19 for chronic kidney disease is currently recruiting, sponsored by Hospices Civils de Lyon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FGF19 (FGF19)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Chronic Kidney Diseases | NA | Status: RECRUITING